Oncology

Comprehensive biomarker solutions for clinical development in:

1. Immuno-Oncology

  • Central pathology evaluation
  • PD-L1 IHC (22C3, 28-8, SP263,142)
  • Microsatellite instability (qPCR,NGS)
  • Mismatch repair (IHC)
  • Tumor mutation burden (NGS)

2. Targeted Therapy

  • MET (IHC,FISH)
  • ERBB2(IHC,FISH,ddPCR)
  • EGFR mutation (Cobas, ddPCR, NGS)
  • B-raf mutation (Cobas)
  • K-Ras/N-Ras mutation (Cobas)
  • BRCA1/2 mutation (NGS)
  • HRD assessment (NGS)

Besides detection and diagnosis in traditional hematological diseases, Teddy lab also provides in CAR-T related biomarker service for 10+ clinical trials

3. CAR-T

  • CAR-T PK (qPCR,ddPCR, FCM)
  • Cytokines (MSD, ELISA, FCM)
  • Immunophenotyping analysis (FCM)
  • CAR-T immunogenicity(ADA)
  • Replicable lentivirus (qPCR)
  • Minimal residual disease (FCM)

Teddylab Services

We have a wide variety of services based on test platforms supporting routine safety, flow cytometry, anatomic and molecular pathology, PK/BE, and companion diagnostics. We act as a one-stop central lab to provide better services for comprehensive, harmonized clinical trials in this era of progress.

Infectious Disease

Endocrinology

Oncology

Inflammation

Hematology

Precision Medicine

About Teddylab

A CAP certified and NGSP certified Level I Laboratory, Teddy Clinical Research Laboratory is a joint venture of Tigermed and DiAn Diagnostic, and is dedicated to providing high-quality central lab services for clinical research and development.